Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Bakhshinyan, David  [Clear All Filters]
2023
Kameda-Smith MM, Zhu H, Luo E-C, Suk Y, Xella A, Yee B, Chokshi C, Xing S, Tan F, Fox RG, et al. Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma. Nat Commun. 2023;14(1):136.
2022
Kameda-Smith MM, Zhu H, Luo E-C, Suk Y, Xella A, Yee B, Chokshi C, Xing S, Tan F, Fox RG, et al. Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma. Nat Commun. 2022;13(1):7506.
Qazi MA, Salim SK, Brown KR, Mikolajewicz N, Savage N, Han H, Subapanditha MK, Bakhshinyan D, Nixon A, Vora P, et al. Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma. Cell Rep. 2022;40(13):111420.
2020
Vora P, Venugopal C, Salim SKhalid, Tatari N, Bakhshinyan D, Singh M, Seyfrid M, Upreti D, Rentas S, Wong N, et al. The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma. Cell Stem Cell. 2020.
2019
Vora P, Seyfrid M, Venugopal C, Qazi MA, Salim S, Isserlin R, Subapanditha M, O'Farrell E, Mahendram S, Singh M, et al. Bmi1 regulates human glioblastoma stem cells through activation of differential gene networks in CD133+ brain tumor initiating cells. J Neurooncol. 2019.